Old Web
English
Sign In
Acemap
>
authorDetail
>
Pam Schwartz
Pam Schwartz
Pfizer
Ponezumab
Disease
Psychology
Diabetes mellitus
Psychiatry
2
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, tolerability, pharmacokinetics and pharmacodynamics of monthly and quarterly doses of Ponezumab (PF-04360365) in subjects with mild-to-moderate Alzheimer's disease
2012
Alzheimers & Dementia
Jaren W. Landen
Niels Andreasen
Carol Cronenberger
Pam Schwartz
Anne Börjesson-Hanson
Henrik Östlund
Catherine Sattler
James W. Kupiec
Brendon Binneman
Martin M. Bednar
Show All
Source
Cite
Save
Citations (4)
Effect of ponezumab on CSF biomarkers: Pooled analysis of phase IIa studies in subjects with mild-to-moderate Alzheimer's disease
2012
Alzheimers & Dementia
Carol Cronenberger
Pam Schwartz
Kathryn Wright
Kelly R. Bales
Kaj Blennow
Henrik Zetterberg
Jaren W. Landen
Scot Styren
Nathan Chen
Brendon Binneman
Show All
Source
Cite
Save
Citations (24)
1